Martingale Asset Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-17,408
| Closed | -$310K | – | 879 |
|
|
2021
Q3 | $310K | Buy |
17,408
+9,100
| +110% | +$162K | ﹤0.01% | 746 |
|
|
2021
Q2 | $374K | Buy |
+8,308
| New | +$374K | ﹤0.01% | 673 |
|
|
2020
Q4 | – | Sell |
-43,700
| Closed | -$855K | – | 1017 |
|
|
2020
Q3 | $855K | Sell |
43,700
-53,500
| -55% | -$1.05M | 0.01% | 676 |
|
|
2020
Q2 | $1.72M | Buy |
+97,200
| New | +$1.72M | 0.02% | 582 |
|